Clinical trial
A 19-week Cognition Study of Levetiracetam in Children With Partial Onset…
NCT00105040 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00105040 |
|---|---|
| Title | A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures |
| Official title | A 19-week, Randomized, Double-blind, Multicenter, Placebo-controlled Safety Study to Evaluate the Cognitive and Neuropsychological Effects of Levetiracetam 20 - 60 mg/kg/Day, Divided in Twice Daily Dosing, as Adjunctive Treatment in Children 4 - 16 Years Old, Inclusive, With Refractory Partial Onset… |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug, Other |
| Interventions | Levetiracetam, Placebo (PB) |
| Enrollment | 87 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Mar 4, 2005 |
| Last update posted | Mar 2, 2015 |
| Countries | Canada, South Africa, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: